FDA Approved: TADALAFIL — Supplemental Application (Cipla USA Inc.)

View source ↗

Summary

The FDA approved a supplemental application for tadalafil from Cipla USA Inc. under ANDA210255, expanding the approved generic product for additional use or for…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia
• Erectile Dysfunction
• Pulmonary Arterial Hypertension

Drugs mentioned

• TADALAFIL (TADALAFIL)

Snippet

SUPPL AP for TADALAFIL (TADALAFIL)